← Open Payments lookup

ASIM ULUSARAC: Open Payments

NPI 1730151671 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,851 in 190 payments from 20 companies in 2025. Trend: 2023 $2,366 · 2024 $2,523 · 2025 $2,851

Food & beverage: $2,851
CompanyPaymentsAmount
ABBVIE INC.34$520
Otsuka America Pharmaceutical, Inc.31$385
Janssen Pharmaceuticals, Inc8$336
Teva Pharmaceuticals USA, Inc.17$226
Supernus Pharmaceuticals, Inc.25$180
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$157
Lundbeck LLC14$150
Vanda Pharmaceuticals Inc.10$135
Brainsway USA INC1$108
Bausch Health US, LLC4$97

Products named: VRAYLAR, REXULTI, SPRAVATO, AUSTEDO XR, Qelbree, CAPLYTA, Deep TMS System, FANAPT.

Industry payments across MO — which companies pay providers there.